Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (1003)	2/17/2000 10:34:00 AM
From: arnie h	Read Replies (1) \| Respond to of 1386

David: With all due respect, the chance of a company with 40 or so employees and no experience being successful in conducting such a difficult study as this will entail is negligible. Further, the amount of money needed is well beyond the company's resources. Fortunately, Dr. Aviv appears to understand this and has stated he is determined to get a partner for it. I for one can only hope he continues in that approach. With positive results from the 3rd cohort and a good partner, we should do quite well indeed. Cheers, Arnie